Business Description
Orthofix Medical Inc., founded in 1980 and headquartered in Lewisville, Texas, operates as a global medical technology company focusing on devices and biologics. Its reach extends across the United States, several European nations including Italy, Germany, France, and the United Kingdom, as well as Brazil and other international markets. The company's operations are divided into two main segments: Global Spine and Global Orthopedics. Within the Global Spine division, Orthofix is responsible for the development, production, and distribution of bone growth stimulators. These devices are designed to facilitate bone fusion and serve as a therapeutic intervention for fractures located outside the spine and in the limbs. This segment also creates and commercializes a range of motion preservation and fixation implant products utilized in spinal surgical procedures. Furthermore, it supplies physicians with various tissue forms and synthetic-based regenerative biologic solutions to address a wide spectrum of spinal and orthopedic conditions. The Global Orthopedics segment concentrates on the design, development, and commercialization of specialized orthopedic products. These offerings are essential for procedures involving fracture repair, the correction of deformities, and bone reconstruction. Orthofix distributes its products to a diverse clientele, including physicians, hospitals, outpatient surgery centers, and integrated health delivery systems. This is achieved through a comprehensive sales network that includes its own sales force, independent distributors, and both employed and external sales representatives. The company, previously known as Orthofix International N.V., officially changed its name to Orthofix Medical Inc. in July 2018.
Business History
Price Overview
Last updated: Jun 27, 2026 8:56am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -2.28
Total Equity: $450.04M
Shares: 39,883,000
Total Debt: $186.79M
Cash: $82.03M
EBITDA: -$22.35M
Total Debt: $186.79M
Cash: $82.03M
Revenue: $822.31M
Shares: 39,883,000
Revenue: $822.31M
Revenue: $822.31M
Revenue: $822.31M
Total Equity: $450.04M
Tax Rate: -1.5%
Equity: $450.04M
Total Debt: $186.79M
Cash: $82.03M
Current Liabilities: $170.48M
Long-Term Debt: $182.80M
Total Debt: $186.79M
Total Equity: $450.04M
Shares: 39,883,000
Shares: 39,883,000
CapEx: -$34.63M
Shares: 39,883,000
Stock Price: $9.78
Net Income: -$92.19M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 21, 2026 1:05pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $464.5M | $460.7M | $746.6M | $799.5M | $822.3M |
| Cost of Revenue | $114.9M | $123.5M | $260.4M | $253.6M | $270.6M |
| Gross Profit | $349.6M | $337.2M | $486.3M | $545.9M | $551.7M |
| Operating Expenses | $357.9M | $350.4M | $625.4M | $630.5M | $620.2M |
| Operating Income | -$8.3M | -$13.3M | -$139.1M | -$84.6M | -$68.5M |
| Net Income | -$38.4M | -$19.7M | -$151.4M | -$126.0M | -$92.2M |
| EBITDA | $21.4M | $15.7M | -$79.5M | -$34.2M | -$22.4M |
| EPS | $-1.95 | $-0.98 | $-4.12 | $-3.30 | $-2.28 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 21, 2026 1:05pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $87.8M | $50.7M | $33.1M | $83.2M | $82.0M |
| Total Current Assets | $269.5M | $256.0M | $420.4M | $433.3M | $416.8M |
| Total Assets | $476.6M | $458.6M | $925.3M | $893.3M | $850.6M |
| Current Liabilities | $105.8M | $83.6M | $165.2M | $168.6M | $170.5M |
| Long-Term Debt | $0 | $0 | $93.1M | $157.0M | $182.8M |
| Total Liabilities | $139.7M | $121.8M | $326.6M | $390.2M | $400.6M |
| Total Equity | $336.9M | $336.9M | $598.7M | $503.1M | $450.0M |
| Retained Earnings | $21.0M | $1.3M | -$150.1M | -$276.1M | -$368.3M |
Cash Flow (Annual)
Last updated: Jun 21, 2026 1:05pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $18.5M | -$11.5M | -$45.8M | $25.8M | $33.3M |
| Capital Expenditure | -$19.6M | -$23.2M | -$62.1M | -$34.9M | -$34.6M |
| Free Cash Flow | -$1.1M | -$34.7M | -$107.8M | -$9.1M | -$1.3M |
| Acquisitions (net) | $0 | -$1.5M | $29.4M | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$9.0M | -$37.1M | -$12.9M | $48.0M | $-623,000 |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 8:56am (just now)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$881.8M $875.8M – $893.8M
|
$930.7M $922.9M – $944.0M
|
$1.0B $995.5M – $1.0B
|
$1.1B $1.0B – $1.1B
|
| EBITDA |
-$17.0M -$17.2M – -$16.9M
|
-$17.9M -$18.2M – -$17.8M
|
-$19.3M -$19.6M – -$19.2M
|
-$20.3M -$20.6M – -$20.2M
|
| Net Income |
-$40.4M -$41.0M – -$39.8M
|
-$26.6M -$42.7M – -$3.2M
|
$0 | $0 |
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 21, 2026 1:05pm (5d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | -0.8% | +62.1% | +7.1% | +2.9% |
| Gross Profit Growth | -3.5% | +44.2% | +12.3% | +1.1% |
| Operating Income Growth | -59.6% | -948.5% | +39.2% | +19.1% |
| Net Income Growth | +48.5% | -666.6% | +16.8% | +26.8% |
| EBITDA Growth | -27.0% | -607.7% | +57.0% | +34.6% |
Insider Trading (Recent)
All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-18 | McPherron Aviva | S-Sale | 3,670.00 | $9.38 | $34,425 |
| 2026-06-10 | Bazaar Alan Lee | A-Award | 14,965.00 | $0.00 | $0 |
| 2026-06-10 | Kummeth Charles R. | A-Award | 14,965.00 | $0.00 | $0 |
| 2026-06-10 | Hannon Jason | A-Award | 14,965.00 | $0.00 | $0 |
| 2026-06-10 | Finegan Michael | A-Award | 20,721.00 | $0.00 | $0 |
| 2026-06-10 | CAPPS VICKIE L | A-Award | 14,965.00 | $0.00 | $0 |
| 2026-06-10 | HENNEMAN JOHN B III | A-Award | 14,965.00 | $0.00 | $0 |
| 2026-06-10 | BURRIS WAYNE | A-Award | 14,965.00 | $0.00 | $0 |
| 2026-06-10 | Maniar Shweta | A-Award | 14,965.00 | $0.00 | $0 |
| 2026-06-10 | Paolucci Michael E | A-Award | 14,965.00 | $0.00 | $0 |
| 2026-05-22 | Juniper Investment Company, LLC | S-Sale | 242,000.00 | $10.70 | $2.6M |
| 2026-05-21 | Juniper Investment Company, LLC | 0.00 | $0.00 | $0 | |
| 2026-05-21 | Juniper Investment Company, LLC | 0.00 | $0.00 | $0 | |
| 2026-05-21 | Juniper Investment Company, LLC | 0.00 | $0.00 | $0 | |
| 2026-05-07 | HENNEMAN JOHN B III | P-Purchase | 5,000.00 | $12.26 | $61,295 |
| 2026-05-07 | Engine Capital Management, LP | P-Purchase | 9,096.00 | $12.15 | $110,490 |
| 2026-05-07 | Engine Capital Management, LP | P-Purchase | 18,192.00 | $12.20 | $221,901 |
| 2026-05-06 | Engine Capital Management, LP | P-Purchase | 38,154.00 | $12.23 | $466,547 |
| 2026-05-05 | Engine Capital Management, LP | P-Purchase | 110,039.00 | $11.99 | $1.3M |
| 2026-05-07 | Engine Capital Management, LP | P-Purchase | 904.00 | $12.15 | $10,981 |
Narrative Economics
market-narrative step).